icon-    folder.gif   Conference Reports for NATAP  
 
  (APASL) 23rd Conference of the Asian Pacific
Association for the Study of the Liver
6-9 June
2013, Singapore
Back grey_arrow_rt.gif
 
 
 
Early on-treatment HBsAg level predicts response in HBeAg-positive chronic hepatitis B patients switched from long-term entecavir to peginterferon alfa-2a (40KD)
 
 
  Reported by Jules levin
APASL Liver Week 2013; 6-10 June, Singapore
 
Q. Ning,1 M. Han,1 Y. Sun,2 J. Jiang,3 D. Tan,4 J. Hou,5 H. Tang,6 J. Sheng,7 M. Zhao8 1Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2Tangdu Hospital, The Fourth Military Medical University, Xi'an, China; 3The First Hospital, Fujian Medical University, Fuzhou, China; 4Xiangya Hospital, Central South University, Changsha, China; 5Nanfang Hospital, Nanfang Medical University, Guangzhou, China; 6West China Hospital, Sichuan University, Chengdu, China; 7The First Hospital, Zhejiang University, Hangzhou, China; 8Shanghai Roche Pharmaceutical Co., Ltd, Shanghai, China

APASL1.gif

APASL2.gif

APASL3.gif

APASL4.gif

APASL5.gif

APASL6.gif

APASL7.gif

APASL8.gif